LO
Lobe Sciences Ltd.
LOBEF · OTC
$0.05 -1.33% (-$0.00)
1M -2.38%
Market Cap $20.8M
P/E Ratio -
Div. Yield -
ROE 338.76%
Bulios Fair Price
$0.07
33.1% upside
Trenutna cena
$0.053
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LOBEF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 11.02x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 74.15%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 193.51%
ROE 338.76%
ROA 93.31%
Debt
69 /100
Low Debt/Equity 0.18x
Current ratio 2.38x
Int. coverage -27.35x
Stability
29 /100
Unstable Beta 0.28x
EPS volatility 40.66%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LOBEF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frederick Dominick Sancilio
Employees
0
Headquarters
Vancouver
Prihajajoči dogodki
28 DEC.
Earnings
Upcoming earnings report